EQT
50
-4
EQIX
50
-3
AES
55
-3
BK
74
-5
CNP
52
2
CMA
73
-4
ETR
52
-2
ALLE
46
-7
D
41
4
ABT
41
3
AAP
12
-14
CMCSA
42
8
BBY
45
-4
AA
67
-5
DD
55
-4
CI
52
3
EL
56
4
C
79
-2
CMI
72
-5
CCL
65
-3
EQT
50
-4
EQIX
50
-3
AES
55
-3
BK
74
-5
CNP
52
2
CMA
73
-4
ETR
52
-2
ALLE
46
-7
D
41
4
ABT
41
3
AAP
12
-14
CMCSA
42
8
BBY
45
-4
AA
67
-5
DD
55
-4
CI
52
3
EL
56
4
C
79
-2
CMI
72
-5
CCL
65
-3
Financhill
Back

NICE Ltd. (Israel) Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
40

NICE
NICE Ltd. (Israel)

Last Price:
$109.28
Seasonality Move:
4.07%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.24
Seasonality Move:
6.21%
Sell
40
NICE Ltd. (Israel) (NICE) is a Sell

Is NICE Ltd. (Israel) a Buy, Sell or Hold?

  • The current NICE Ltd. (Israel) [NICE] share price is $109.24. The Score for NICE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NICE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NICE Stock Price Chart

What is NICE Ltd. (Israel)'s stock price today?

  • The NICE Ltd. (Israel) share price today is $109.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NICE is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

NICE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.49 Sell
Relative Strength Index (14 RSI): 42.92 Sell
Chaikin Money Flow: -98908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.84 - 121.64) Sell
Bollinger Bands (100): (118.19 - 150.37) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

NICE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.36 Buy
20-day SMA: 107.98 Buy
50-day SMA: 122.55 Sell
200-day SMA: 146.42 Sell
8-day EMA: 107.87 Buy
20-day EMA: 110.61 Sell
50-day EMA: 120.46 Sell
200-day EMA: 143.72 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

NICE Ltd. (Israel) Earnings Growth & NICE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and a decrease next year of $1.14 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

NICE Ltd. (Israel) Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):